alantolactone has been researched along with Cachexia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuang, JX; Li, YW; Liu, X; Miao, CX; Shen, Q; Zhang, WL; Zhang, XW | 1 |
1 other study(ies) available for alantolactone and Cachexia
| Article | Year |
|---|---|
Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Topics: Animals; Cachexia; Humans; Lactones; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Sesquiterpenes, Eudesmane; Signal Transduction; STAT3 Transcription Factor | 2022 |